Uncarboxylated Osteocalcin Decreases SCD1 by Activating AMPK to Alleviate Hepatocyte Lipid Accumulation
Molecules · 31.03.2023 · 28 (7) · 3121
DOI: 10.3390/molecules28073121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 31.03.2023. Verfasst von Danqing Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Savaid Medical School, University of Chinese Academy of Sciences, Beijing 101400, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Uncarboxylated osteocalcin (GluOC), a small-molecule protein specifically synthesized and secreted by osteoblasts, is important in the regulation of energy metabolism. In our previous study, GluOC was shown to be effective in ameliorating dyslipidemia and hepatic steatosis in KKAy mice. However, the underlying mechanism of GluOC action on hepatocytes has not been well validated. In this study, oleic acid/palmitic acid (OA/PA)-induced HepG2 and NCTC 1469 cells were used as non-alcoholic fatty liver disease (NAFLD) cell models, and triacylglycerol (TG) levels were measured by oil red O staining, Nile Red staining, and ELISA. The fatty acid synthesis-related protein expression was detected by real-time quantitative polymerase chain reaction, Western blotting, and immunofluorescence. The results show that GluOC reduced triglyceride levels, and decreased the expression of sterol regulatory element-binding protein-1c (SREBP-1c) and stearyl-coenzyme A desaturase 1 (SCD1). si-SCD1 mimicked the lipid accumulation-reducing effect of GluOC, while overexpression of SCD1 attenuated the effect of GluOC. In addition, GluOC activated AMP-activated protein kinase (AMPK) phosphorylation to affect lipid metabolism in hepatocytes. Overall, the results of this study suggest that GluOC decreases SCD1 by activating AMPK to alleviate hepatocyte lipid accumulation, which provides a new target for improving NAFLD in further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Savaid Medical School, University of Chinese Academy of Sciences, Beijing 101400, China.
Förderung
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, D., Zhang, M., Xu, J., & Yang, J. (2023). Uncarboxylated Osteocalcin Decreases SCD1 by Activating AMPK to Alleviate Hepatocyte Lipid Accumulation. Molecules, 28(7), 3121. https://doi.org/10.3390/molecules28073121
Vancouver
Wang D, Zhang M, Xu J, Yang J. Uncarboxylated Osteocalcin Decreases SCD1 by Activating AMPK to Alleviate Hepatocyte Lipid Accumulation. Molecules. 2023;28(7):3121. doi:10.3390/molecules28073121
BibTeX
@article{Wang2023,
author = {Wang, Danqing and Zhang, Miao and Xu, Jiaojiao and Yang, Jianhong},
title = {Uncarboxylated Osteocalcin Decreases SCD1 by Activating AMPK to Alleviate Hepatocyte Lipid Accumulation},
journal = {Molecules},
year = {2023},
volume = {28},
number = {7},
pages = {3121},
doi = {10.3390/molecules28073121}
}
EUVIMED